|
Jul 31
|
Vaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in Infants
|
|
Jul 31
|
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Jul 31
|
The three-year shareholder returns and company earnings persist lower as Pfizer (NYSE:PFE) stock falls a further 6.1% in past week
|
|
Jul 31
|
Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says
|
|
Jul 31
|
Stay Ahead of the Game With Pfizer (PFE) Q2 Earnings: Wall Street's Insights on Key Metrics
|
|
Jul 31
|
AbbVie (ABBV) Tops Q2 Earnings and Revenue Estimates
|
|
Jul 31
|
Marengo Therapeutics Bolsters Advisory Strength with Appointment of Dr. Mikael Dolsten to its Board of Directors and Dr. Josep Tabernero to its Scientific Advisory Board
|
|
Jul 31
|
Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
|
|
Jul 31
|
Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer
|
|
Jul 31
|
Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON
|
|
Jul 31
|
Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health
|
|
Jul 31
|
Where Will Pfizer (PFE) Be in 5 Years?
|
|
Jul 31
|
Ireland awakens to the risk of relying on US investment
|
|
Jul 31
|
Bank of America Securities Maintains a Hold on Pfizer (PFE)
|
|
Jul 30
|
UPS Stock Joins 7% Dividend Yielders in S&P 500. Here’s Who Else Is in That Club.
|
|
Jul 30
|
Pfizer’s (PFE) Breakthrough Medicines Power its Dividend Stability
|
|
Jul 30
|
Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?
|
|
Jul 30
|
Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?
|
|
Jul 30
|
Time to Go Short on Pfizer (PFE)?
|
|
Jul 30
|
Australia Anti-Venom Market Analysis Report 2025-2033 Featuring BSV, Boehringer Ingelheim, Boston Scientific, CSL, Merck, Pfizer, Haffkine Bio-Pharmaceutical
|